The CatapultRx programme is a targeted initiative designed to accelerate the growth of high-potential SMEs in the Medicines Manufacturing sector.

2025 has been a pivotal year, marked by strategic investments and new national and international partnerships in areas such as RNA, batteries, and engineering biology, which will define the UK’s next industrial chapter. 

Organisations from across the North East’s health and life sciences sector are being urged to have their say on the challenges and opportunities facing the industry.